Loiola, Rodrigo Azevedo
García-Gabilondo, Miguel
Grayston, Alba
Bugno, Paulina
Kowalska, Agnieszka
Duban-Deweer, Sophie
Rizzi, Eleonora
Hachani, Johan
Sano, Yasuteru
Shimizu, Fumitaka
Kanda, Takashi
Mysiorek, Caroline
Mazurek, Maciej Piotr
Rosell, Anna
Gosselet, Fabien http://orcid.org/0000-0002-0481-5026
Funding for this research was provided by:
agence nationale de la recherche (ANR-17-ENM3-0005-01)
ministerio de ciencia e innovación (PCIN-2017-090)
horizon 2020 (764958)
european regional development fund (SMART platform)
Instituto de Salud Carlos III (AC17/00004, FI17/00073)
Generalitat de Catalunya (2017-SGR-1427, SLT017/20/000197)
Article History
Received: 28 June 2021
Accepted: 25 September 2021
First Online: 26 October 2021
Change Date: 27 February 2024
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1186/s13287-024-03667-7
Declarations
:
: Informed consent was obtained from all subjects with the approval of the Clinical Ethics Committee of the Hospital Vall d’Hebron (PR-AG-177-2011/2021). Collection of human umbilical cord blood was done with the signature of a consent form by infant’s parents, in compliance with the French legislation. The protocol was approved by the French Ministry of Higher Education and Research (CODECOH Number DC2011-1321). All experiments were carried out in accordance with the approved protocol.
: Not applicable.
: PB, AK, and MM are employees of Pure Biologics S.A. Authors report no competing interests.